Search

everythinglearnresearchcommunity

for

Search:↓

A 63-year-old woman's male-like symptoms were caused by a rare testosterone-producing ovarian tumor, treated by removing her ovaries and fallopian tubes.

The effects of estrogen on human scalp hair growth are unclear and need more research.

A patient with a severe type of hair loss experienced partial hair regrowth after treatment with a specific light therapy and a medication called interferon α2a.

The research created a detailed map of skin cells, showing that certain cells in basal cell carcinoma may come from hair follicles and could help the cancer grow.

A rare benign tumor was found in a man's scrotum, highlighting the need for accurate diagnosis.

Tumor immunotherapy can cause hair loss by disrupting hair follicle immunity.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

After chemotherapy for a gestational trophoblastic tumor, normal pregnancy rates are possible, but there's a slightly higher risk of the tumor reoccurring in future pregnancies.

Different types of skin cells have unique genetic markers that affect how likely they are to spread cancer.

Meis1 is crucial for skin health and tumor development.

The research found that MRI and certain hormone levels can help tell apart ovarian tumors from hyperthecosis in postmenopausal women, but tissue analysis is still needed for a definite diagnosis.

Chronic scalp pain in trichodynia involves both body-wide and localized increased pain sensitivity.

The document concludes that new methods improve the accuracy of diagnosing scalp alopecia and challenges the old way of classifying it.

The study found new details about human hair growth and suggests that preventing a specific biological pathway could potentially treat hair graying.

Self-assessed hirsutism scores are not reliable for clinical diagnosis but may help in screening.

Tumor-targeted drug carriers can improve chemotherapy precision and reduce side effects.

Wnt and Shh signaling are key in noggin-induced tumors, and blocking them can slow tumor growth.

Human scalp hair follicles have PGE2 and its receptors, which might affect hair growth.

Most children with CNS tumors on targeted therapy had skin reactions, which were generally treatable without stopping the therapy.

Intramuscular injections improved hair density more than intradermal injections for treating hair loss.

A rare ovarian tumor caused high testosterone and excess hair in a woman, which was resolved after tumor removal.

Personalized treatment based on detailed tumor analysis successfully managed and reduced the patient's aggressive hair follicle cancer.

New genes found linked to balding, may help develop future treatments.

Lupus can affect the scalp and nails, often causing hair loss and nail damage, and needs early aggressive treatment to prevent permanent damage.

A new triple drug system using nanoparticles effectively targets breast tumors in 3D models.

Telocytes in the scalp may help with skin regeneration and maintenance.

Triptorelin helps evaluate hormone production in Sertoli-Leydig cell tumors.

NKIRAS2 can suppress certain skin tumors but its effect on cancer varies with context and expression level.

AIDS may cause changes in the scalp that increase infection risk and hair loss.

Baldness may lower the risk of testicular cancer.